Yadin Rozov - 12 Nov 2025 Form 4 Insider Report for Core Scientific, Inc./tx (CORZ)

Reporting relationship: Director
Issuer ticker: CORZ
Reported as of: 12 Nov 2025
Net transaction value: +$298,440
SEC form: 4
Accepted by SEC: 13 Nov 2025, 16:53:11 UTC
Prior SEC filing: 12 Sep 2025
Next SEC filing: 02 Jan 2026
Source filing: View source filing
Reporting owner signature: /s/ Todd DuChene, as Attorney-in-Fact

Key filing fact

Yadin Rozov filed Form 4 for Core Scientific, Inc./tx (CORZ) on 13 Nov 2025.

Key facts

This page summarizes Yadin Rozov's Form 4 filing for Core Scientific, Inc./tx (CORZ).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Nov 2025, 16:53.

Change

Previous filing in this sequence was filed on 12 Sep 2025.
Current net transaction value: +$298,440.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001921268 Primary reporting owner

Rozov Yadin

Relationship: Director
Address: C/O CORE SCIENTIFIC, INC., 838 WALKER ROAD, SUITE 21-2105, DOVER
Signature: /s/ Todd DuChene, as Attorney-in-Fact
Signature date: 13 Nov 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CORZ transaction Derivative

Tranche 1 Warrants

Purchase

Transaction value: $298,440
Shares: +30,000
Change %
Price: $9.95
Shares after: 30,000
Date: 12 Nov 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 30,000
Exercise price: $6.81
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Each whole Tranche 1 Warrant entitles the registered holder to purchase one whole share of the Issuer's common stock at an exercise price of $6.81 per share, subject to certain adjustments.

Footnote F2

The price reported is a weighted average price. These Tranche 1 Warrants were purchased in multiple transactions at prices ranging from $9.85 to $10.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Tranche 1 Warrants purchased at each separate price within such range.